B. Ashleigh Guadagnolo is a Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. Her research focuses on clinical radiation oncology for sarcomas and rare malignancies, including the role of combined modality therapy in soft tissue sarcoma, adjuvant radiotherapy for cutaneous melanoma with microsatellitosis, and the natural history of myoepithelial carcinoma. She leads the SATURN-STS phase II trial investigating neoadjuvant atezolizumab with doxorubicin and pre-operative radiation for high-risk extremity sarcoma. She co-authored the ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma, endorsed by ASTRO, and has published extensively in the Journal of Clinical Oncology and Annals of Surgical Oncology.
See moreHonors

Experiences

Education
